These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35677501)

  • 21. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.
    Harrison SA; Ruane PJ; Freilich B; Neff G; Patil R; Behling C; Hu C; Shringarpure R; de Temple B; Fong E; Tillman EJ; Rolph T; Cheng A; Yale K
    JHEP Rep; 2023 Jan; 5(1):100563. PubMed ID: 36644237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Bezzi M; Lombardo CV; Romaggioli S; Ferraro F; Bascetta S; Chiesa C
    World J Gastroenterol; 2013 Jul; 19(25):4007-14. PubMed ID: 23840146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased bone mineral density in patients with non-alcoholic steatohepatitis.
    Kaya M; Işık D; Beştaş R; Evliyaoğlu O; Akpolat V; Büyükbayram H; Kaplan MA
    World J Hepatol; 2013 Nov; 5(11):627-34. PubMed ID: 24303091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low free triiodothyronine levels are associated with frail phenotype in hospitalized inpatients with cirrhosis.
    Li C; Zhao C; Yu Z; Yang W; Sun M; Li Y; Guo G; Hui Y; Wang X; Fan X; Wang B; Zhang J; Sun C
    Postgrad Med; 2022 Jun; 134(5):516-523. PubMed ID: 35382681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.
    Bale A; Pai CG; Shetty S; Balaraju G; Shetty A
    J Clin Exp Hepatol; 2018 Jun; 8(2):156-161. PubMed ID: 29892178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis.
    Siramolpiwat S; Kiattikunrat K; Soontararatpong R; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanun P; Issariyakulkarn N
    Scand J Gastroenterol; 2021 Oct; 56(10):1210-1219. PubMed ID: 34338110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in frailty and its association with low bone mineral density in rheumatoid arthritis.
    Wysham KD; Shoback DM; Andrews JS; Katz PP
    Bone Rep; 2020 Jun; 12():100284. PubMed ID: 32509932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MALNUTRITION IN CIRRHOSIS: ASSOCIATION WITH ETIOLOGY AND HEPATOCELLULAR DYSFUNCTION.
    Oliveira KS; Oliveira LR; Fernandes SA; Coral GP
    Arq Gastroenterol; 2020; 57(4):375-380. PubMed ID: 33331472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease.
    Karoli Y; Karoli R; Fatima J; Manhar M
    J Clin Diagn Res; 2016 Aug; 10(8):OC31-4. PubMed ID: 27656483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malnutrition and its association with the mortality in liver cirrhosis; a prospective nutritional assessment in two referral centers in Iran.
    Pashayee-Khamene F; Hajimohammadebrahim-Ketabforoush M; Shahrbaf MA; Saadati S; Karimi S; Hatami B; Rashidkhani B; Ahmadzadeh S; Kord-Varkaneh H; Hekmatdoost A
    Clin Nutr ESPEN; 2023 Apr; 54():453-458. PubMed ID: 36963894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density loss in patients with cirrhosis.
    Muhsen IN; AlFreihi O; Abaalkhail F; AlKhenizan A; Khan M; Eldali A; Alsohaibani F
    Saudi J Gastroenterol; 2018; 24(6):342-347. PubMed ID: 29943736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Frailty in Patients With Liver Cirrhosis.
    Panezai MQ; Taha Yaseen R; Ahmed Khan S; Abrar G; Ali Khalid M; Ul Haque MM; Lail G; Kumar D; Laeeq SM; Hassan Luck N
    Cureus; 2024 Jun; 16(6):e61626. PubMed ID: 38966454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and plasma protein biomarkers associated with frailty in patients with cirrhosis.
    Ha NB; Seetharaman S; Kent DS; Yao F; Shui AM; Huang CY; Walston J; Lai JC
    Liver Transpl; 2023 Oct; 29(10):1089-1099. PubMed ID: 36932707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cirrhosis on bone mineral density and bone metabolism.
    Turkeli M; Dursun H; Albayrak F; Okçu N; Uyanik MH; Uyanik A; Yıldırım R; Keleş M; Yılmaz O
    Eurasian J Med; 2008 Apr; 40(1):18-24. PubMed ID: 25610017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of abnormal bone mass density in adult patients with homozygous sickle-cell disease.
    Garadah TS; Hassan AB; Jaradat AA; Diab DE; Kalafalla HO; Kalifa AK; Sequeira RP; Alawadi AH
    Clin Med Insights Endocrinol Diabetes; 2015; 8():35-40. PubMed ID: 25987854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional assessment in hepatic cirrhosis; clinical, anthropometric, biochemical and hematological parameters.
    Vieira PM; De-Souza DA; Oliveira LC
    Nutr Hosp; 2013; 28(5):1615-21. PubMed ID: 24160225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OUTCOME AND NUTRITIONAL ASSESSMENT OF CHRONIC LIVER DISEASE PATIENTS USING ANTHROPOMETRY AND SUBJECTIVE GLOBAL ASSESSMENT.
    Nunes G; Santos CA; Barosa R; Fonseca C; Barata AT; Fonseca J
    Arq Gastroenterol; 2017; 54(3):225-231. PubMed ID: 28723979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys.
    Baeg MK; Yoon SK; Ko SH; Han KD; Choi HJ; Bae SH; Choi JY; Choi MG
    Hepatol Int; 2016 May; 10(3):470-7. PubMed ID: 26850597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma.
    Hirota K; Kawaguchi T; Koya S; Nagamatsu A; Tomita M; Hashida R; Nakano D; Niizeki T; Matsuse H; Shiba N; Torimura T
    Hepatol Res; 2020 Mar; 50(3):330-341. PubMed ID: 31721387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease.
    Duarte MP; Farias ML; Coelho HS; Mendonça LM; Stabnov LM; do Carmo d Oliveira M; Lamy RA; Oliveira DS
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1022-7. PubMed ID: 11595067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.